The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vaccines and Drugs for Duck Market Research Report 2025
Synopsis
The global Vaccines and Drugs for Duck market was valued at US$ 2132.1 million in 2023 and is anticipated to reach US$ 2793.7 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
In recent years, the large-scale breeding of various types of livestock and poultry has developed steadily and rapidly. Large-scale breeding enterprises pay more attention to epidemic prevention and control, and have greater demand for high-quality vaccines, which has brought good development opportunities for poultry biological products enterprises, especially leading enterprises in the industry.
This report aims to provide a comprehensive presentation of the global market for Vaccines and Drugs for Duck, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines and Drugs for Duck.
Report Scope
The Vaccines and Drugs for Duck market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccines and Drugs for Duck market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccines and Drugs for Duck manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Ceva Santé Animale
QYH Biotech
Merck Animal Health
Zoetis
ChengDu Tecbond
Elanco
FATRO
Vaksindo
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Zhaoqing Dahuanong Biology Medicine
Segment by Type
Drugs
Vaccines
Segment by Application
Farm
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaccines and Drugs for Duck manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaccines and Drugs for Duck in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Vaccines and Drugs for Duck market was valued at US$ 2132.1 million in 2023 and is anticipated to reach US$ 2793.7 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
In recent years, the large-scale breeding of various types of livestock and poultry has developed steadily and rapidly. Large-scale breeding enterprises pay more attention to epidemic prevention and control, and have greater demand for high-quality vaccines, which has brought good development opportunities for poultry biological products enterprises, especially leading enterprises in the industry.
This report aims to provide a comprehensive presentation of the global market for Vaccines and Drugs for Duck, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines and Drugs for Duck.
Report Scope
The Vaccines and Drugs for Duck market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccines and Drugs for Duck market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccines and Drugs for Duck manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Ceva Santé Animale
QYH Biotech
Merck Animal Health
Zoetis
ChengDu Tecbond
Elanco
FATRO
Vaksindo
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Zhaoqing Dahuanong Biology Medicine
Segment by Type
Drugs
Vaccines
Segment by Application
Farm
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaccines and Drugs for Duck manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaccines and Drugs for Duck in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Vaccines and Drugs for Duck Market Overview
1.1 Product Overview and Scope of Vaccines and Drugs for Duck
1.2 Vaccines and Drugs for Duck Segment by Type
1.2.1 Global Vaccines and Drugs for Duck Market Value Comparison by Type (2024-2030)
1.2.2 Drugs
1.2.3 Vaccines
1.3 Vaccines and Drugs for Duck Segment by Application
1.3.1 Global Vaccines and Drugs for Duck Market Value by Application: (2024-2030)
1.3.2 Farm
1.3.3 Others
1.4 Global Vaccines and Drugs for Duck Market Size Estimates and Forecasts
1.4.1 Global Vaccines and Drugs for Duck Revenue 2019-2030
1.4.2 Global Vaccines and Drugs for Duck Sales 2019-2030
1.4.3 Global Vaccines and Drugs for Duck Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vaccines and Drugs for Duck Market Competition by Manufacturers
2.1 Global Vaccines and Drugs for Duck Sales Market Share by Manufacturers (2019-2024)
2.2 Global Vaccines and Drugs for Duck Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Vaccines and Drugs for Duck Average Price by Manufacturers (2019-2024)
2.4 Global Vaccines and Drugs for Duck Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccines and Drugs for Duck, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccines and Drugs for Duck, Product Type & Application
2.7 Vaccines and Drugs for Duck Market Competitive Situation and Trends
2.7.1 Vaccines and Drugs for Duck Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vaccines and Drugs for Duck Players Market Share by Revenue
2.7.3 Global Vaccines and Drugs for Duck Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vaccines and Drugs for Duck Retrospective Market Scenario by Region
3.1 Global Vaccines and Drugs for Duck Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vaccines and Drugs for Duck Global Vaccines and Drugs for Duck Sales by Region: 2019-2030
3.2.1 Global Vaccines and Drugs for Duck Sales by Region: 2019-2024
3.2.2 Global Vaccines and Drugs for Duck Sales by Region: 2025-2030
3.3 Global Vaccines and Drugs for Duck Global Vaccines and Drugs for Duck Revenue by Region: 2019-2030
3.3.1 Global Vaccines and Drugs for Duck Revenue by Region: 2019-2024
3.3.2 Global Vaccines and Drugs for Duck Revenue by Region: 2025-2030
3.4 North America Vaccines and Drugs for Duck Market Facts & Figures by Country
3.4.1 North America Vaccines and Drugs for Duck Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vaccines and Drugs for Duck Sales by Country (2019-2030)
3.4.3 North America Vaccines and Drugs for Duck Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vaccines and Drugs for Duck Market Facts & Figures by Country
3.5.1 Europe Vaccines and Drugs for Duck Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vaccines and Drugs for Duck Sales by Country (2019-2030)
3.5.3 Europe Vaccines and Drugs for Duck Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccines and Drugs for Duck Market Facts & Figures by Country
3.6.1 Asia Pacific Vaccines and Drugs for Duck Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vaccines and Drugs for Duck Sales by Country (2019-2030)
3.6.3 Asia Pacific Vaccines and Drugs for Duck Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Vaccines and Drugs for Duck Market Facts & Figures by Country
3.7.1 Latin America Vaccines and Drugs for Duck Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vaccines and Drugs for Duck Sales by Country (2019-2030)
3.7.3 Latin America Vaccines and Drugs for Duck Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccines and Drugs for Duck Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccines and Drugs for Duck Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vaccines and Drugs for Duck Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vaccines and Drugs for Duck Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaccines and Drugs for Duck Sales by Type (2019-2030)
4.1.1 Global Vaccines and Drugs for Duck Sales by Type (2019-2024)
4.1.2 Global Vaccines and Drugs for Duck Sales by Type (2025-2030)
4.1.3 Global Vaccines and Drugs for Duck Sales Market Share by Type (2019-2030)
4.2 Global Vaccines and Drugs for Duck Revenue by Type (2019-2030)
4.2.1 Global Vaccines and Drugs for Duck Revenue by Type (2019-2024)
4.2.2 Global Vaccines and Drugs for Duck Revenue by Type (2025-2030)
4.2.3 Global Vaccines and Drugs for Duck Revenue Market Share by Type (2019-2030)
4.3 Global Vaccines and Drugs for Duck Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vaccines and Drugs for Duck Sales by Application (2019-2030)
5.1.1 Global Vaccines and Drugs for Duck Sales by Application (2019-2024)
5.1.2 Global Vaccines and Drugs for Duck Sales by Application (2025-2030)
5.1.3 Global Vaccines and Drugs for Duck Sales Market Share by Application (2019-2030)
5.2 Global Vaccines and Drugs for Duck Revenue by Application (2019-2030)
5.2.1 Global Vaccines and Drugs for Duck Revenue by Application (2019-2024)
5.2.2 Global Vaccines and Drugs for Duck Revenue by Application (2025-2030)
5.2.3 Global Vaccines and Drugs for Duck Revenue Market Share by Application (2019-2030)
5.3 Global Vaccines and Drugs for Duck Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Vaccines and Drugs for Duck Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer Ingelheim Vaccines and Drugs for Duck Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Ceva Santé Animale
6.2.1 Ceva Santé Animale Corporation Information
6.2.2 Ceva Santé Animale Description and Business Overview
6.2.3 Ceva Santé Animale Vaccines and Drugs for Duck Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ceva Santé Animale Vaccines and Drugs for Duck Product Portfolio
6.2.5 Ceva Santé Animale Recent Developments/Updates
6.3 QYH Biotech
6.3.1 QYH Biotech Corporation Information
6.3.2 QYH Biotech Description and Business Overview
6.3.3 QYH Biotech Vaccines and Drugs for Duck Sales, Revenue and Gross Margin (2019-2024)
6.3.4 QYH Biotech Vaccines and Drugs for Duck Product Portfolio
6.3.5 QYH Biotech Recent Developments/Updates
6.4 Merck Animal Health
6.4.1 Merck Animal Health Corporation Information
6.4.2 Merck Animal Health Description and Business Overview
6.4.3 Merck Animal Health Vaccines and Drugs for Duck Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Animal Health Vaccines and Drugs for Duck Product Portfolio
6.4.5 Merck Animal Health Recent Developments/Updates
6.5 Zoetis
6.5.1 Zoetis Corporation Information
6.5.2 Zoetis Description and Business Overview
6.5.3 Zoetis Vaccines and Drugs for Duck Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zoetis Vaccines and Drugs for Duck Product Portfolio
6.5.5 Zoetis Recent Developments/Updates
6.6 ChengDu Tecbond
6.6.1 ChengDu Tecbond Corporation Information
6.6.2 ChengDu Tecbond Description and Business Overview
6.6.3 ChengDu Tecbond Vaccines and Drugs for Duck Sales, Revenue and Gross Margin (2019-2024)
6.6.4 ChengDu Tecbond Vaccines and Drugs for Duck Product Portfolio
6.6.5 ChengDu Tecbond Recent Developments/Updates
6.7 Elanco
6.6.1 Elanco Corporation Information
6.6.2 Elanco Description and Business Overview
6.6.3 Elanco Vaccines and Drugs for Duck Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Elanco Vaccines and Drugs for Duck Product Portfolio
6.7.5 Elanco Recent Developments/Updates
6.8 FATRO
6.8.1 FATRO Corporation Information
6.8.2 FATRO Description and Business Overview
6.8.3 FATRO Vaccines and Drugs for Duck Sales, Revenue and Gross Margin (2019-2024)
6.8.4 FATRO Vaccines and Drugs for Duck Product Portfolio
6.8.5 FATRO Recent Developments/Updates
6.9 Vaksindo
6.9.1 Vaksindo Corporation Information
6.9.2 Vaksindo Description and Business Overview
6.9.3 Vaksindo Vaccines and Drugs for Duck Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Vaksindo Vaccines and Drugs for Duck Product Portfolio
6.9.5 Vaksindo Recent Developments/Updates
6.10 Ringpu Biology
6.10.1 Ringpu Biology Corporation Information
6.10.2 Ringpu Biology Description and Business Overview
6.10.3 Ringpu Biology Vaccines and Drugs for Duck Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Ringpu Biology Vaccines and Drugs for Duck Product Portfolio
6.10.5 Ringpu Biology Recent Developments/Updates
6.11 Yebio
6.11.1 Yebio Corporation Information
6.11.2 Yebio Vaccines and Drugs for Duck Description and Business Overview
6.11.3 Yebio Vaccines and Drugs for Duck Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Yebio Vaccines and Drugs for Duck Product Portfolio
6.11.5 Yebio Recent Developments/Updates
6.12 Harbin Veterinary Research Institute
6.12.1 Harbin Veterinary Research Institute Corporation Information
6.12.2 Harbin Veterinary Research Institute Vaccines and Drugs for Duck Description and Business Overview
6.12.3 Harbin Veterinary Research Institute Vaccines and Drugs for Duck Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Harbin Veterinary Research Institute Vaccines and Drugs for Duck Product Portfolio
6.12.5 Harbin Veterinary Research Institute Recent Developments/Updates
6.13 Zhaoqing Dahuanong Biology Medicine
6.13.1 Zhaoqing Dahuanong Biology Medicine Corporation Information
6.13.2 Zhaoqing Dahuanong Biology Medicine Vaccines and Drugs for Duck Description and Business Overview
6.13.3 Zhaoqing Dahuanong Biology Medicine Vaccines and Drugs for Duck Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Zhaoqing Dahuanong Biology Medicine Vaccines and Drugs for Duck Product Portfolio
6.13.5 Zhaoqing Dahuanong Biology Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccines and Drugs for Duck Industry Chain Analysis
7.2 Vaccines and Drugs for Duck Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccines and Drugs for Duck Production Mode & Process
7.4 Vaccines and Drugs for Duck Sales and Marketing
7.4.1 Vaccines and Drugs for Duck Sales Channels
7.4.2 Vaccines and Drugs for Duck Distributors
7.5 Vaccines and Drugs for Duck Customers
8 Vaccines and Drugs for Duck Market Dynamics
8.1 Vaccines and Drugs for Duck Industry Trends
8.2 Vaccines and Drugs for Duck Market Drivers
8.3 Vaccines and Drugs for Duck Market Challenges
8.4 Vaccines and Drugs for Duck Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Vaccines and Drugs for Duck Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Vaccines and Drugs for Duck Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Vaccines and Drugs for Duck Market Competitive Situation by Manufacturers in 2023
Table 4. Global Vaccines and Drugs for Duck Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Vaccines and Drugs for Duck Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Vaccines and Drugs for Duck Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Vaccines and Drugs for Duck Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Vaccines and Drugs for Duck Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Vaccines and Drugs for Duck, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Vaccines and Drugs for Duck, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vaccines and Drugs for Duck, Product Type & Application
Table 12. Global Key Manufacturers of Vaccines and Drugs for Duck, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vaccines and Drugs for Duck by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines and Drugs for Duck as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vaccines and Drugs for Duck Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Vaccines and Drugs for Duck Sales by Region (2019-2024) & (K Units)
Table 18. Global Vaccines and Drugs for Duck Sales Market Share by Region (2019-2024)
Table 19. Global Vaccines and Drugs for Duck Sales by Region (2025-2030) & (K Units)
Table 20. Global Vaccines and Drugs for Duck Sales Market Share by Region (2025-2030)
Table 21. Global Vaccines and Drugs for Duck Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Vaccines and Drugs for Duck Revenue Market Share by Region (2019-2024)
Table 23. Global Vaccines and Drugs for Duck Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Vaccines and Drugs for Duck Revenue Market Share by Region (2025-2030)
Table 25. North America Vaccines and Drugs for Duck Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Vaccines and Drugs for Duck Sales by Country (2019-2024) & (K Units)
Table 27. North America Vaccines and Drugs for Duck Sales by Country (2025-2030) & (K Units)
Table 28. North America Vaccines and Drugs for Duck Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Vaccines and Drugs for Duck Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Vaccines and Drugs for Duck Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Vaccines and Drugs for Duck Sales by Country (2019-2024) & (K Units)
Table 32. Europe Vaccines and Drugs for Duck Sales by Country (2025-2030) & (K Units)
Table 33. Europe Vaccines and Drugs for Duck Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Vaccines and Drugs for Duck Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Vaccines and Drugs for Duck Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Vaccines and Drugs for Duck Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Vaccines and Drugs for Duck Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Vaccines and Drugs for Duck Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Vaccines and Drugs for Duck Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Vaccines and Drugs for Duck Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Vaccines and Drugs for Duck Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Vaccines and Drugs for Duck Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Vaccines and Drugs for Duck Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Vaccines and Drugs for Duck Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Vaccines and Drugs for Duck Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Vaccines and Drugs for Duck Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Vaccines and Drugs for Duck Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Vaccines and Drugs for Duck Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Vaccines and Drugs for Duck Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Vaccines and Drugs for Duck Sales (K Units) by Type (2019-2024)
Table 51. Global Vaccines and Drugs for Duck Sales (K Units) by Type (2025-2030)
Table 52. Global Vaccines and Drugs for Duck Sales Market Share by Type (2019-2024)
Table 53. Global Vaccines and Drugs for Duck Sales Market Share by Type (2025-2030)
Table 54. Global Vaccines and Drugs for Duck Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Vaccines and Drugs for Duck Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Vaccines and Drugs for Duck Revenue Market Share by Type (2019-2024)
Table 57. Global Vaccines and Drugs for Duck Revenue Market Share by Type (2025-2030)
Table 58. Global Vaccines and Drugs for Duck Price (US$/Unit) by Type (2019-2024)
Table 59. Global Vaccines and Drugs for Duck Price (US$/Unit) by Type (2025-2030)
Table 60. Global Vaccines and Drugs for Duck Sales (K Units) by Application (2019-2024)
Table 61. Global Vaccines and Drugs for Duck Sales (K Units) by Application (2025-2030)
Table 62. Global Vaccines and Drugs for Duck Sales Market Share by Application (2019-2024)
Table 63. Global Vaccines and Drugs for Duck Sales Market Share by Application (2025-2030)
Table 64. Global Vaccines and Drugs for Duck Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Vaccines and Drugs for Duck Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Vaccines and Drugs for Duck Revenue Market Share by Application (2019-2024)
Table 67. Global Vaccines and Drugs for Duck Revenue Market Share by Application (2025-2030)
Table 68. Global Vaccines and Drugs for Duck Price (US$/Unit) by Application (2019-2024)
Table 69. Global Vaccines and Drugs for Duck Price (US$/Unit) by Application (2025-2030)
Table 70. Boehringer Ingelheim Corporation Information
Table 71. Boehringer Ingelheim Description and Business Overview
Table 72. Boehringer Ingelheim Vaccines and Drugs for Duck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Boehringer Ingelheim Vaccines and Drugs for Duck Product
Table 74. Boehringer Ingelheim Recent Developments/Updates
Table 75. Ceva Santé Animale Corporation Information
Table 76. Ceva Santé Animale Description and Business Overview
Table 77. Ceva Santé Animale Vaccines and Drugs for Duck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Ceva Santé Animale Vaccines and Drugs for Duck Product
Table 79. Ceva Santé Animale Recent Developments/Updates
Table 80. QYH Biotech Corporation Information
Table 81. QYH Biotech Description and Business Overview
Table 82. QYH Biotech Vaccines and Drugs for Duck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. QYH Biotech Vaccines and Drugs for Duck Product
Table 84. QYH Biotech Recent Developments/Updates
Table 85. Merck Animal Health Corporation Information
Table 86. Merck Animal Health Description and Business Overview
Table 87. Merck Animal Health Vaccines and Drugs for Duck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Merck Animal Health Vaccines and Drugs for Duck Product
Table 89. Merck Animal Health Recent Developments/Updates
Table 90. Zoetis Corporation Information
Table 91. Zoetis Description and Business Overview
Table 92. Zoetis Vaccines and Drugs for Duck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Zoetis Vaccines and Drugs for Duck Product
Table 94. Zoetis Recent Developments/Updates
Table 95. ChengDu Tecbond Corporation Information
Table 96. ChengDu Tecbond Description and Business Overview
Table 97. ChengDu Tecbond Vaccines and Drugs for Duck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. ChengDu Tecbond Vaccines and Drugs for Duck Product
Table 99. ChengDu Tecbond Recent Developments/Updates
Table 100. Elanco Corporation Information
Table 101. Elanco Description and Business Overview
Table 102. Elanco Vaccines and Drugs for Duck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Elanco Vaccines and Drugs for Duck Product
Table 104. Elanco Recent Developments/Updates
Table 105. FATRO Corporation Information
Table 106. FATRO Description and Business Overview
Table 107. FATRO Vaccines and Drugs for Duck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. FATRO Vaccines and Drugs for Duck Product
Table 109. FATRO Recent Developments/Updates
Table 110. Vaksindo Corporation Information
Table 111. Vaksindo Description and Business Overview
Table 112. Vaksindo Vaccines and Drugs for Duck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Vaksindo Vaccines and Drugs for Duck Product
Table 114. Vaksindo Recent Developments/Updates
Table 115. Ringpu Biology Corporation Information
Table 116. Ringpu Biology Description and Business Overview
Table 117. Ringpu Biology Vaccines and Drugs for Duck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Ringpu Biology Vaccines and Drugs for Duck Product
Table 119. Ringpu Biology Recent Developments/Updates
Table 120. Yebio Corporation Information
Table 121. Yebio Description and Business Overview
Table 122. Yebio Vaccines and Drugs for Duck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Yebio Vaccines and Drugs for Duck Product
Table 124. Yebio Recent Developments/Updates
Table 125. Harbin Veterinary Research Institute Corporation Information
Table 126. Harbin Veterinary Research Institute Description and Business Overview
Table 127. Harbin Veterinary Research Institute Vaccines and Drugs for Duck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Harbin Veterinary Research Institute Vaccines and Drugs for Duck Product
Table 129. Harbin Veterinary Research Institute Recent Developments/Updates
Table 130. Zhaoqing Dahuanong Biology Medicine Corporation Information
Table 131. Zhaoqing Dahuanong Biology Medicine Description and Business Overview
Table 132. Zhaoqing Dahuanong Biology Medicine Vaccines and Drugs for Duck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Zhaoqing Dahuanong Biology Medicine Vaccines and Drugs for Duck Product
Table 134. Zhaoqing Dahuanong Biology Medicine Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Vaccines and Drugs for Duck Distributors List
Table 138. Vaccines and Drugs for Duck Customers List
Table 139. Vaccines and Drugs for Duck Market Trends
Table 140. Vaccines and Drugs for Duck Market Drivers
Table 141. Vaccines and Drugs for Duck Market Challenges
Table 142. Vaccines and Drugs for Duck Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vaccines and Drugs for Duck
Figure 2. Global Vaccines and Drugs for Duck Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Vaccines and Drugs for Duck Market Share by Type in 2023 & 2030
Figure 4. Drugs Product Picture
Figure 5. Vaccines Product Picture
Figure 6. Global Vaccines and Drugs for Duck Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Vaccines and Drugs for Duck Market Share by Application in 2023 & 2030
Figure 8. Farm
Figure 9. Others
Figure 10. Global Vaccines and Drugs for Duck Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Vaccines and Drugs for Duck Market Size (2019-2030) & (US$ Million)
Figure 12. Global Vaccines and Drugs for Duck Sales (2019-2030) & (K Units)
Figure 13. Global Vaccines and Drugs for Duck Average Price (US$/Unit) & (2019-2030)
Figure 14. Vaccines and Drugs for Duck Report Years Considered
Figure 15. Vaccines and Drugs for Duck Sales Share by Manufacturers in 2023
Figure 16. Global Vaccines and Drugs for Duck Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Vaccines and Drugs for Duck Players: Market Share by Revenue in 2023
Figure 18. Vaccines and Drugs for Duck Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Vaccines and Drugs for Duck Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Vaccines and Drugs for Duck Sales Market Share by Country (2019-2030)
Figure 21. North America Vaccines and Drugs for Duck Revenue Market Share by Country (2019-2030)
Figure 22. United States Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Vaccines and Drugs for Duck Sales Market Share by Country (2019-2030)
Figure 25. Europe Vaccines and Drugs for Duck Revenue Market Share by Country (2019-2030)
Figure 26. Germany Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Vaccines and Drugs for Duck Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Vaccines and Drugs for Duck Revenue Market Share by Region (2019-2030)
Figure 33. China Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Vaccines and Drugs for Duck Sales Market Share by Country (2019-2030)
Figure 43. Latin America Vaccines and Drugs for Duck Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Vaccines and Drugs for Duck Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Vaccines and Drugs for Duck Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Vaccines and Drugs for Duck Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Vaccines and Drugs for Duck by Type (2019-2030)
Figure 53. Global Revenue Market Share of Vaccines and Drugs for Duck by Type (2019-2030)
Figure 54. Global Vaccines and Drugs for Duck Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Vaccines and Drugs for Duck by Application (2019-2030)
Figure 56. Global Revenue Market Share of Vaccines and Drugs for Duck by Application (2019-2030)
Figure 57. Global Vaccines and Drugs for Duck Price (US$/Unit) by Application (2019-2030)
Figure 58. Vaccines and Drugs for Duck Value Chain
Figure 59. Vaccines and Drugs for Duck Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
